Haemodynamic effects of AT1 inhibition and Ca2+-channel blockade in hypertensive patients during isometric stress

Journal of Human Hypertension

Volumn 20, Issue 3, 2006, Pages 201-205

  Arosio, E ^a   De Marchi, S ^a   Prior, M ^a   Rigoni, A ^a   Lechi, A ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Amlodipine; Handgrip; Microcirculation; Peripheral resistance; Valsartan

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE; VALSARTAN;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOREARM; HAND GRIP; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PHYSIOLOGY; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE; VASCULARIZATION;

AMLODIPINE; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOREARM; HAND STRENGTH; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLETHYSMOGRAPHY; TETRAZOLES; VALINE; VASCULAR RESISTANCE;

EID: 33745918012     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001963     Document Type: Article

References (33)

1. Stroth U, Unger T. The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol 1999; 33(Suppl 1): S21-S28; discussion s41-s43. (Pubitemid 29072062)
2. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodim and potassium homeostasis. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. Raven Press Ltd: New York, NY, 1995, pp 1763-1796.
3. Zimmerman BG. Adrenergic facilitation by angiotensin: does it serve a physiological funcion? Clin Sci 1981; 60: 343-348. (Pubitemid 11123437)
4. Hollander AP, Bouman LN. Cardiac acceleration in man elicited by a muscle-heart reflex. J Appl Physiol 1975; 38: 272-278.
5. Burnier M, Brunner HR. Angiotensin II receptor antagonists. The Lancet 2000; 355: 637-645. (Pubitemid 30099477)
6. Timmermans PB. Angiotensin II receptor antagonists; an emerging new class of cardiovascular therapeutics. Hypertension Res 1999; 22: 147-153.
7. Oparil S, Duke S, Harris F, Kief J, James D, Hester A et al. The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension. Clin Ther 1996; 18: 797-810. (Pubitemid 26397279)
8. Thurmann PA. Angiotensin II antagonism and the heart: valsartan in left biventricular hypertrophy. J Cardiovasc Pharmacol, 1999; 33(Suppl 1): s33-s36; discussion s41-s43. (Pubitemid 29072064)
9. Cohn JN. Improving outcomes in congestive heart failure: Val-Heft. Valsartan in heart failure trial. Cardiology 1999; 91: 19-22. (Pubitemid 29371543)
10. Muek A, Seeger H, Lippert TH. Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery. Int J Clin Pharmacol Ther 1999; 37: 365-366. (Pubitemid 29338494)
11. Peeters AC, Netea MG, Kullberg BJ, Thien T, van der Meer JW. The effect of renin-angiotensin system inhibitors on pro-and anti-inflammatory cytokine production. Immunology 1998; 94: 376-379. (Pubitemid 28318603)
12. Mervaala EM, Muller DN, Park JK, Schmidt F, Lon M, Breu V et al. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension 1999; 33(Part 2): 389-395. (Pubitemid 29065690)
13. Gibbons GH. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting inhibition: the homeostatic balance between angiotensin II and nitric oxide. Clin Cardiol 1997; 20(Suppl 2): II-18-II-25. (Pubitemid 28009559)
14. Tayeh MA, Scicli AG. Angiotensin II and bradikinin regulate the expression of P-selectin on the surface of endothelial cells in culture. Proc Assoc Am Physicians 1998; 110: 412-421. (Pubitemid 28421929)
15. Rahn KH, Barenbrock M, Hausberg M. The sympathetic nervous system in the pathogenesis of hypertension. J Hypertens 1999; 17(Suppl 3): S11-S14.
16. Ohlsein EH, Brooks DP, Feurestein GZ, Ruffolo Jr RR. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist. Pharmacology 1997; 55: 244-251.
17. Pancera P, Arosio E, Priante F, Ribul M, De Marchi S, Lechi A. Haemodynamic changes induced by cilazapril and atenolol during isometric stress in hypertensive patients. Int J Clin Pharmacol Ther and Toxicol 1993; 31: 582-587. (Pubitemid 23355438)
18. Sumner DS. Volume plethysmgraphy in vascular disease: an overview. In: Bernstein EF (ed). Vascular diagnosis. Mosby: St Louis, 1993, pp 181-193.
19. Pancera P, Sansone S, Secchi S, Covi G, Lechi A. The effect of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon. J Int Med 1997; 242: 373-376. (Pubitemid 27513101)
20. Kappert A. Oscillografia acrale. In: Angiologia - First italian edition of Lehrbuck und atlas der Angiologie. Verlag Hans Huber: Twelfth edition Berna, 1991, pp 69-71.
21. Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium dependent dilation in hypertensive patients undergoing isometric stress. J Hypertens 2002; 20: 1793-1797.
22. Asmar R. Arterial Pulse Wave. In: Arterial Stiffness and Pulse Wave Velocity Clincal Applications. Elsevier ed.: Paris France, 1999, pp 17-23.
23. Milasseau SC, Guigui FG, Kelly RP, Prasad K, Crockcroft JR, Ritter JM et al. Non invasive assessment of the digital volume pulse. Hypertension 2000; 36: 952.
24. Ceru S, Pancera P, Sansone S, Sfondrini G, Codella O, De Sandre G et al. Effects of five day versus one day infusion of iloprost on the peripheral microcirculation in patients with systemic sclerosis. Clin Exp Rheumatol 1997; 15: 381-385. (Pubitemid 27323999)
25. Grossman E, Oren S, Garavaglia GE, Schmieder R, Messerli FH. Disparate haemodynamic and sympathoadrenergic responses to isometric and mental stress in essential hypertension. Am J Cardiol 1989; 64: 42-44. (Pubitemid 19166206)
26. Graafsma SJ, Wan Tits LJ, Wan Heijts P, Reyenga J, Rodrigues de Miranda JF et al. Effects of isometric exercise on blood cell adrenoceptors in essential hypertension. J Cardiovasc Pharmacol 1989; 14: 598-602. (Pubitemid 19232769)
27. Minuz P, Pancera P, Ribul M, Priante F, Degan M, Campedelli A et al. Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition. Br J Clin Pharmacol 1995; 39: 45-50.
28. Spence JD, Munoz C, Murray WH, Sonya T. Effect of amlodipine on haemodynamic and endocrine responses to mental stress. Am J Hypertens 2000; 13(Part 1): 518-522. (Pubitemid 30330714)
29. Nazzaro P, Mnazari M, Merlo M, Triggiani R, Scarano AM, Lasciarrea A et al. Antihypertensive treatment with verapamil and amlodipine. Their effect on the functional autonomic and cardiovascular stress responses. Eur Heart J 1995; 16: 1277-1284.
30. Sevre K, Lefrandt JD, Eide I, Smit AJ, Rostrup M. Less adrenergic response to mental task during verapamil compared to amlodipine treatment in hypertensive subjects. Blood Press 2001; 10: 111-115. (Pubitemid 32651669)
31. Widdop RE, Matrougiu K, Levy BI, Henrion D. AT2 receptor-mediated relaxation is preserved after longterm AT1 receptor blockade. Hypertension 2002; 40: 516-520.
32. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac Hypertrophy, aortic compliance, peripheral resistance and wave reflection in end stage renal disease. Circulation 1994; 90: 2786-2796.
33. Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension 2002; 40: 521-524.